These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7486634)

  • 21. A randomized double-blind controlled trial of naftidrofuryl in acute stroke.
    Gray CS; French JM; Venables GS; Cartlidge NE; James OF; Bates D
    Age Ageing; 1990 Nov; 19(6):356-63. PubMed ID: 2285001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Controlled study of piribedil as compared to placebos in cerebral pathology].
    Schöling W
    Minerva Med; 1976 May; 67(26):1733-5. PubMed ID: 778671
    [No Abstract]   [Full Text] [Related]  

  • 23. A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib.
    Zohlnhöfer D; Hausleiter J; Kastrati A; Mehilli J; Goos C; Schühlen H; Pache J; Pogatsa-Murray G; Heemann U; Dirschinger J; Schömig A
    J Am Coll Cardiol; 2005 Dec; 46(11):1999-2003. PubMed ID: 16325031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group.
    Clark WM; Warach SJ; Pettigrew LC; Gammans RE; Sabounjian LA
    Neurology; 1997 Sep; 49(3):671-8. PubMed ID: 9305321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of cerebrovascular deficiencies. Therapeutic evaluation from 129 cases using the double-blind method against placebo].
    Bargheon J; Durocher AM; Lagrange M
    Sem Hop; 1984 Jan; 60(3):169-74. PubMed ID: 6320441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
    Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
    Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrolysin dose-dependently improves neurological outcome in rats after acute stroke: A prospective, randomized, blinded, and placebo-controlled study.
    Zhang L; Chopp M; Lu M; Zhang T; Winter S; Doppler E; Meier D; Chao L; Eapen A; Pabla P; Gang Zhang Z
    Int J Stroke; 2016 Apr; 11(3):347-55. PubMed ID: 26763925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of cavinton on the hemorheological parameters of chronic cerebrovascular patients].
    Sapary L; Horvath B; Alexy T; Marton Z; Kesmarky G; Zsots M; Nagy F; Czopf I; Toth K
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(6):47-51. PubMed ID: 16841484
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial.
    Mischoulon D; Witte J; Levy M; Papakostas GI; Pet LR; Hsieh WH; Pencina MJ; Ward S; Pollack MH; Fava M
    J Clin Psychiatry; 2012 Mar; 73(3):353-7. PubMed ID: 21939613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The neuroprotective effect of calcitonin gene-related peptide following subarachnoid hemorrhage. European CGRP in Subarachnoid Haemorrhage Study Group.
    Bell BA
    Ann N Y Acad Sci; 1995 Sep; 765():299-300. PubMed ID: 7486617
    [No Abstract]   [Full Text] [Related]  

  • 31. Imatinib dose escalation to achieve molecular responses in patients with chronic myeloid leukemia in late chronic phase.
    Stagno F; Vigneri P; Del Fabro V; Stella S; Massimino M; Berretta S; Messina A; Di Raimondo F
    Leuk Res; 2009 Jun; 33(6):e17. PubMed ID: 19036439
    [No Abstract]   [Full Text] [Related]  

  • 32. [A multicenter program on assessment of efficacy and safety of a new therapeutic scheme for patients with chronic cerebrovascular insufficiency].
    Skoromets AA; Tanashian MM; Chukanova EI; Petrova EA; Spirin NN; Nikonov AA; Peverennova IE; Levin IaI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5 Suppl 2):44-8. PubMed ID: 19894300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proceedings: Effects of piribedil (ET 495)--a dopaminergic receptor stimulating agent in Parkinson's disease.
    Lieberman A; Le Brun Y; Zolfaghari M
    Psychopharmacol Bull; 1974 Jul; 10(3):42-3. PubMed ID: 4419369
    [No Abstract]   [Full Text] [Related]  

  • 34. [Parallel double-blind clinical trial of nifedipine versus a placebo in patients with chronic cerebrovascular insufficiency].
    Vintró Molins C; Viaplana Más JM
    Med Clin (Barc); 1985 Mar; 84(8):308-11. PubMed ID: 3884927
    [No Abstract]   [Full Text] [Related]  

  • 35. A randomized, double-blind, placebo-controlled study of 2 dose ranges of paliperidone extended-release in the treatment of subjects with schizoaffective disorder.
    Canuso CM; Lindenmayer JP; Kosik-Gonzalez C; Turkoz I; Carothers J; Bossie CA; Schooler NR
    J Clin Psychiatry; 2010 May; 71(5):587-98. PubMed ID: 20492853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term data on vicriviroc released.
    AIDS Patient Care STDS; 2009 Nov; 23(11):989. PubMed ID: 19938348
    [No Abstract]   [Full Text] [Related]  

  • 37. Neuroprotective effects of the glutamate release inhibitor 619C89 in temporary middle cerebral artery occlusion.
    Kawaguchi K; Graham SH
    Brain Res; 1997 Feb; 749(1):131-4. PubMed ID: 9070637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sildenafil citrate (Viagra) in the treatment of men with erectile dysfunction in southern Latin America: a double-blind, randomized, placebo-controlled, parallel-group, multicenter, flexible-dose escalation study.
    Becher E; Tejada Noriega A; Gomez R; Decia R;
    Int J Impot Res; 2002 Aug; 14 Suppl 2():S33-41. PubMed ID: 12161766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A double-blind controlled clinical study on the use of mucopolysaccharides in the treatment of patients with cerebral vasculopathy. Comparison with a placebo].
    Bardin P; Campo R
    Clin Ter; 1987 Jan; 120(2):111-8. PubMed ID: 2972439
    [No Abstract]   [Full Text] [Related]  

  • 40. On the inhibition of voltage activated calcium currents in rat cortical neurones by the neuroprotective agent 619C89.
    Stefani A; Hainsworth AH; Spadoni F; Bernardi G
    Br J Pharmacol; 1998 Nov; 125(5):1058-64. PubMed ID: 9846645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.